Efficacy of afatinib in the clinical practice: Final results of the GIDEON study in EGFR mutated non-small cell lung cancer (NSCLC) in Germany. The impact of prior chemotherapy (PrC) on immunotherapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback